HIV Infections

Showing NaN - NaN of 357

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV, Cognitive Impairment Trial in Birmingham, Aurora, Seattle (Phase 1 Gym Exercise HIIT, Phase 1 Gym Exercise CME, Phase 2

Not yet recruiting
  • HIV Infections
  • Cognitive Impairment
  • Phase 1 Gym Exercise HIIT
  • +3 more
  • Birmingham, Alabama
  • +2 more
Aug 22, 2023

Implementation and Delivery of Cabotegravir Long Acting

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Seattle, Washington
  • +1 more
May 16, 2023

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023

Consent for Use of Stored Patient Specimens for Future Testing

Recruiting
  • HIV Infections
    • Los Angeles, California
    • +62 more
    Dec 7, 2022

    HIV Trial in United States (APRETUDE, Cabotegravir OLI)

    Recruiting
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 24, 2022

    HIV Trial in South Africa, Thailand, United States (Doravirine (DOR), Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

    Completed
    • HIV Infections
    • Doravirine (DOR)
    • +2 more
    • Aurora, Colorado
    • +7 more
    Sep 30, 2022

    Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)

    Completed
    • Lipodystrophy
    • HIV Infections
    • Birmingham, Alabama
    • +46 more
    Sep 16, 2022

    Antiretroviral Drugs and Related Drugs During and After

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +61 more
    Jun 28, 2022

    HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)

    Completed
    • HIV Infections
    • MPER-656 Liposome Vaccine
    • Placebo for MPER-656 Liposome Vaccine
    • Birmingham, Alabama
    • +5 more
    Jun 15, 2022

    Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

    Recruiting
    • Cytomegalovirus Infections
    • +2 more
    • CMV-MVA Triplex
    • Placebo
    • Birmingham, Alabama
    • +11 more
    Jun 20, 2022

    HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

    Recruiting
    • HIV Infections
    • +2 more
    • Letermovir 240 MG Oral Tablet
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jun 20, 2022

    HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)

    Active, not recruiting
    • HIV Infections
    • BG505 SOSIP.664 gp140, adjuvanted
    • Placebo
    • Boston, Massachusetts
    • +2 more
    May 6, 2022

    HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

    Completed
    • HIV Infections
    • Placebo for maraviroc (MVC)
    • +3 more
    • Los Angeles, California
    • +29 more
    Apr 20, 2022

    HIV, Smoking, Smoking Cessation Trial in Seattle (Wellness Intervention for Smokers with HIV)

    Recruiting
    • HIV Infections
    • +2 more
    • Wellness Intervention for Smokers with HIV
    • Seattle, Washington
      VA Puget Sound Health Care System Seattle Division
    Mar 15, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

    Completed
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Birmingham, Alabama
    • +180 more
    Mar 14, 2022

    HIV Trial in Boston, Seattle (VRC07-523LS)

    Completed
    • HIV Infections
    • VRC07-523LS
    • Boston, Massachusetts
    • +1 more
    Mar 4, 2022

    HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

    Recruiting
    • HIV Infections
    • Doravirine 100 Mg
    • +5 more
    • Birmingham, Alabama
    • +22 more
    Feb 22, 2022

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Birmingham, Alabama
    • +25 more
    Feb 8, 2022

    HIV, Non-Alcoholic Fatty Liver Disease Trial in Brazil, United States (Semaglutide)

    Recruiting
    • HIV Infections
    • Non-Alcoholic Fatty Liver Disease
    • Birmingham, Alabama
    • +8 more
    Jan 28, 2022

    HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

    Active, not recruiting
    • HIV Infections
    • DTG 50 mg
    • +2 more
    • Bakersfield, California
    • +61 more
    Dec 3, 2021

    HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

    Recruiting
    • HIV Infections
    • Standard of Care (SOC) Oral ART
    • +6 more
    • Birmingham, Alabama
    • +34 more
    Dec 1, 2021

    HIV Trial in Puerto Rico, United States (Atazanavir, Darunavir, Efavirenz)

    Completed
    • HIV Infections
    • Alhambra, California
    • +22 more
    Nov 3, 2021